Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Sino Biopharmaceutical ( (HK:1177) ) is now available.
Sino Biopharmaceutical Limited’s board of directors has proposed the adoption of amended and restated articles of association to align with recent changes in the Hong Kong Stock Exchange’s Listing Rules, including the expansion of the paperless listing regime and the treasury shares regime. The proposed amendments aim to enhance clarity and make consequential changes, pending shareholder approval at the upcoming annual general meeting.
More about Sino Biopharmaceutical
Sino Biopharmaceutical Limited is a company incorporated in the Cayman Islands, operating in the biopharmaceutical industry. It focuses on the development, manufacturing, and sale of pharmaceutical products, primarily targeting the healthcare market.
YTD Price Performance: 20.0%
Average Trading Volume: 2,321
Technical Sentiment Signal: Sell
Current Market Cap: $8.84B
Learn more about 1177 stock on TipRanks’ Stock Analysis page.